Cargando…
Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis
BACKGROUND AND AIMS: The chemopreventive effect of 5-aminosalicylic acid (5-ASA) in patients with inflammatory bowel disease (IBD) has been widely studied; however, the results remain conflicting. The aim of this study was to systematically review the literature and update evidence concerning effect...
Autores principales: | Qiu, Xinyun, Ma, Jingjing, Wang, Kai, Zhang, Hongjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352032/ https://www.ncbi.nlm.nih.gov/pubmed/27906680 http://dx.doi.org/10.18632/oncotarget.13715 |
Ejemplares similares
-
Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease
por: Hsiao, Shun-Wen, et al.
Publicado: (2022) -
Chemoprevention of N‐Methylnitrosourea‐induced Colon Carcinogenesis by Ursodeoxycholic Acid‐5‐aminosalicylic Acid Conjugate in F344 Rats
por: Narisawa, Tomio, et al.
Publicado: (2002) -
Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysis
por: Zhao, Xiaojing, et al.
Publicado: (2017) -
Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
por: Sood, Ajit, et al.
Publicado: (2020) -
5-Aminosalicylic acid for treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis
por: Cheng, Wenyuan, et al.
Publicado: (2020)